This move reflects the company's belief in the potential of Bitcoin (BTC) and other currencies to provide a return on investment for shareholders and to provide some hedge against the Canadian dollar.

the Company’s intention to retain 100% of the rights to develop products for pharmaceutical and medical uses; the Company’s intention to maintain a portfolio of strategic investments through FSD ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...

the Company’s intention to maintain a portfolio of strategic investments through FSD Strategic Investments Inc.; MZ playing a key role in assisting the Company to enhance its market awareness ...

James Zibarras, partner, is a listed representative of respondent R. Bokhari in FSD Pharma Inc. v Bokhari. He focuses on urgent civil remedies. Nathan Shaheen, partner, is a listed representative of ...

The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada. ASLAN Pharmaceuticals ...

Quantum BioPharma (NASDAQ: QNTM) has retained MZHCI, an MZ Group company, to lead its investor relations and financial communications efforts. The in ...

Quantum BioPharma (NASDAQ: QNTM) announced the successful completion of a clinical trial demonstrating that its dietary supplement, unbuzzdTM, signi ...

Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical ... subsidiary, FSD Strategic Investments Inc., which ...

Quantum BioPharma maintains the rights to develop similar pharmaceutical products ... through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by ...